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Abstract Alcohol dehydrogenase from Sulfolobus solfataricus
(SsADH) is the only enzyme from Archaea among the structur-
ally studied members of the medium-chain ADH family de-
scribed so far. Here, we present the three-dimensional structure
of the apo form of the mutant N249Y which exhibits increased
catalytic activity when compared to the wild-type enzyme. The
substitution, located in the coenzyme binding domain, decreases
the a⁄nity for NAD(H) cofactor. The rearrangement of seg-
ments 248^250 and 270^275, induced by the mutation, suggests
an explanation for the lower coenzyme a⁄nity. This study also
highlights the role in SsADH catalysis of the £exible loops
located at the interface between the catalytic and the coenzyme
domains.
. 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Alcohol dehydrogenases (ADHs) are spread throughout the
three domains of life: Eukarya, Bacteria, and Archaea. Sulfo-
lobus solfataricus ADH (SsADH) is the ¢rst archaeal enzyme
from the medium-chain ADH family for which the 3D struc-
ture was described [1]. It is an NAD(H)-dependent oxidore-
ductase which shows broad substrate speci¢city, high thermo-
stability, and thermophilicity [2]. Its tetrameric structure is a
typical dimer of dimers. Each subunit is formed by two do-
mains, a coenzyme binding domain adopting a Rossmann
fold, and a catalytic domain with two zinc ions playing a
catalytic and a structural role. The overall fold of a single
SsADH monomer is very similar to that of mammalian and
bacterial ADHs [3^5] with major di¡erences observed in the
architecture of the substrate pocket, in the size of the inter-
domain cleft, and in the coordination of both the active site
and the structural zinc ions [1].
Prior to the structural determination, a random mutagene-
sis strategy was adopted in order to ¢nd SsADH mutants
endowed with improved catalytic properties. The mutant
N249Y, containing the substitution in the coenzyme binding
domain, showed strikingly di¡erent properties when com-
pared to the wild-type (wt) enzyme [6]. Indeed, the N249Y
substitution increases by six-fold the turnover number mea-
sured at 65‡C with benzyl alcohol as substrate. The turnover
number for the reverse reaction is also increased, while the
a⁄nity for all substrates decreases. Furthermore, the a⁄nity
for coenzymes is substantially lower than that of the wt pro-
tein (Michaelis constant KM for NADþ, 25-fold greater; KM
for NADH, 16-fold greater; dissociation constant Kd for
NADþ and for NADH, 103-fold greater) [6]. Hence, the sub-
stitution N249Y probably increases the rate of coenzyme dis-
sociation, thereby providing a possible explanation for the
increased turnover since the release of the coenzyme is rate
limiting for catalysis [6].
While considerably a¡ecting the kinetics of the enzyme, the
substitution does not perturb the structural stability. Indeed,
the mutant resistance to heat, denaturants, and proteases
turned out to be similar or even better than the parent pro-
tein.
To evaluate the molecular basis for the change in catalytic
properties, we carried out a crystallographic study of the mu-
tant N249Y SsADH. Given its low a⁄nity for coenzymes,
only crystals of the apo form have been obtained so far.
The apo structure was therefore used to model the interac-
tions between NADH and the coenzyme domain. Here, we
report two crystal structures of the mutant, their comparison
with the native protein, and the implications for coenzyme
binding and activity.
2. Materials and methods
2.1. Crystallization and data collection
The mutant of the SsADH enzyme, Asn249Tyr, was expressed and
puri¢ed from Escherichia coli following the procedure described pre-
viously [6].
Two crystal forms for the N249Y mutant of SsADH enzyme were
obtained at 22‡C by the microbatch method. Crystals of form I were
grown under the same conditions found for the wt enzyme [7] and
di¡racted up to 2.5 AG resolution. They belong to the tetragonal space
group I4122 with one subunit in the asymmetric unit (a.u.), being
isomorphous with wt apo SsADH crystals. In an attempt to optimize
conditions, various additives were added to the crystallization drop. A
second, monoclinic form (form II) was produced in the presence of 25
mM of cobalt chloride. Using macroseeding techniques, large single
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crystals of form II were obtained, which belong to space group C2
with six subunits in the a.u. Form II crystals di¡ract to higher reso-
lution, 1.94 AG , and also show a lower mosaicity (0.3‡) compared to
form I crystals (0.7‡).
Crystals of both forms were transferred to a stabilizing solution
containing 18% glycerol as cryoprotectant. X-ray data were then col-
lected at 100 K using synchrotron sources. Data were processed and
scaled using the DENZO/SCALEPACK package [8]. Data collection
statistics are shown in Table 1.
2.2. Structure determination and re¢nement
2.2.1. Monoclinic form (crystal form II). The N249Y SsADH
structure of the monoclinic form was solved ¢rst, by using the molec-
ular replacement program AMoRe [9]. The crystallographic structure
of the wt protein, missing the loop 246^250 which embodies the mu-
tation, was used as the search model. The rigid body re¢ned solution
resulted in six subunits in the a.u., corresponding to a correlation
coe⁄cient and an R factor of 54.8% and 38.2%, respectively. Four
out of six chains form one tetramer and the remaining two chains
belong to a second tetramer which is generated by the two-fold crys-
tallographic axis.
The re¢nement was performed using the program CNS [10] omit-
ting 5% re£ections for the calculation of Rfree. At the initial stages of
re¢nement, strict non-crystallographic restraints were applied to the
backbone and side chain atoms. Then the weights for the non-crys-
tallographic symmetry (NCS) restraints were relaxed on the basis of
the analysis of the Rfree values over multiple re¢nement runs in which
the NCS weights were varied.
Cycles of re¢nement were alternated with model building using
2Fobs3Fcalc and Fobs3Fcalc electron density maps visualized by the
program O [11]. The ¢nal model (model II) shows R and Rfree factors
of 21.0% and 24.4%, respectively, calculated by using data between 15
and 1.94 AG .
2.2.2. Tetragonal form (crystal form I). The crystal form is iso-
morphous to the wt SsADH crystal form already solved. The mutant
structure was solved in a straightforward manner by using the molec-
ular replacement program AMoRe and the single chain A from
mutant form II as search model. Rigid body re¢nement of the initial
molecular replacement solution gave a correlation coe⁄cient of 76.8%
and an R factor of 33.2% for data to 3.0 AG resolution. Further re¢ne-
ment was carried out using the program CNS, extending the resolu-
tion to 2.5 AG . A total of 8% of the re£ections was used for Rfree
calculations. The ¢nal model accounts for all 347 residues, 120 water
molecules, and two zinc ions resulting in R and Rfree factors of 19.6%
and 23.6%, respectively.
The stereochemistry of both crystalline models was validated with
the program PROCHECK [12]. Re¢nement statistics are shown in
Table 1. The coordinates of N249Y SsADH have been deposited at
the Protein Data Bank with the codes 1NTO, 1NVG for the mono-
clinic and the tetragonal forms, respectively.
3. Results and discussion
3.1. The overall structure
Two crystal forms, a monoclinic and a tetragonal one, were
obtained for the mutant enzyme. The tetragonal crystals are
isomorphous to the wt crystals and contain one subunit in the
a.u. (model I). The monoclinic crystal structure (model II)
includes six independent monomers in the a.u. This provides
the opportunity to compare the structure of the parent en-
zyme with that of its mutant, minimizing the bias that can
be derived by di¡erent packings in the unit cell. Since model
II was determined to the best resolution, it will serve as the
reference model in this discussion.
Final model II was re¢ned to 1.94 AG resolution. Chain A is
the best ordered out of the six chains. Using subunit A as
reference, the average rms deviation over all CK atoms be-
tween this subunit and each of the remaining ¢ve ones is
0.31 AG . The largest di¡erences in the backbone conformation
are observed between chain A and chain C (rmsd= 0.43 AG ).
They re£ect rigid body displacements of individual structural
elements due to di¡erent packing environments. The rmsd
between model II (chain A) and model I is also low (0.41
AG ), thus indicating a substantially unaltered overall conforma-
tion in the two crystal forms. All subunits of the mutant
structures show an interdomain cleft as wide as that found
in the wt apo structure.
Model I and model II display poor electron density in the
same regions, i.e. in the stretch 46^62 (see further discussion
in Section 3.4) and at the N-terminal and C-terminal seg-
ments.
Table 1
Data collection and re¢nement statistics
Crystal form I Crystal form II
Data collection
Synchrotron/beamline ESRF-Grenoble/ID14-4 Elettra-Trieste
Space group I4122 C2
Cell constants (AG , ‡) a= b=125.40, c=117.19 a=215.33, b=91.59, c=118.24, L=99.2
Resolution range (AG ) 25^2.5 (2.59^2.5)a 15^1.94 (2.01^1.94)a
No. of measured/unique re£ections 104 158/15 757 554 277/146 709
Completeness (%) 95.0 (96.9) 87.9 (86.9)
Rmerge (%)b 3.6 (8.8) 3.3 (9.0)
GIf/Gc(I)f 33 (16) 30 (12)
No. of subunits/a.u. 1 6
Solvent content (%) 60 52
Re¢nement
Resolution range (AG ) 25^2.5 15^1.94
R (%)/Rfree (%)c 19.6/23.6 21.0/24.4
No. of non-H protein atoms 2 620 15 709
No. of water molecules 120 633
No. of zinc ions 2 12
Rmsd from ideality
Bonds (AG ) 0.008 0.01
Angles (‡) 1.3 1.5
aStatistics of the highest resolution shell are shown in parentheses.
bRmerge =ghgiMIi(h)3GI(h)fM/ghgiMIi(h)M.
cR, Rfree =ghM(MFcalc(h)M3MFobs(h)M)/ghMFobs(h)MM. The re£ections used in the Rfree calculation constituted 5% and 8% of the total number of re-
£ections for the monoclinic and tetragonal crystal forms, respectively.
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3.2. Mutation site
The substitution N249Y in the coenzyme domain generates
a structural rearrangement of residues 247^250 accompanied
by an adjustment in the conformation of segment 270^275
(between LE and LS) and of segment 280^283, the N-terminal
part of helix KF (Fig. 1).1
The structural changes necessary to accommodate a bulkier
Tyr residue mainly involve the change in residue 248^249
conformations and the reorientation of the peptide plane O
Val270^NGly271. Compared to the wt enzyme, the residue
249 side chain maintains its interaction with the loop 270^
275 (Fig. 2A). In the mutant, a hydrogen bond is formed by
the OH group of Tyr249 and the O of Phe273 (Fig. 2B),
whereas in wt SsADH it is formed by the OD1 of Asn249
and the N of Gly271. The £ipping of the plane 270^271 brings
the main chain O of Val270 into H-bond contact with the N
of Asn248 (Fig. 2A). This interaction establishes a di¡erent
connection between the two adjacent loops which in the wt
enzyme are connected by a hydrogen bond between O of res-
idue 249 and N of Ala275 (Fig. 2B). Because of the di¡erent
conformation of the 248^249 segment, the mutant enzyme
also lacks the interactions between the Asp246 side chain
and the peptide nitrogen atoms of residues 248 and 249.
Slight conformational changes at the 271^275 backbone
between the two mutant structures are also observed. They
are likely due to small variations at the AB dimer interfaces in
the two crystal packings (Fig. 1) and they result in di¡erent
optimized interactions between the side chain of the mutated
residue and the 270^275 backbone. Indeed, in model II, the
main chain O of Phe273 directly interacts with the OH group
of Tyr249, whereas in model I an adjustment of the 271^275
backbone and a small rotation of the Tyr ring favor the
H-bond between the phenolic OH and the O of Gly271.
The comparison of the mutant structure with the wt one
indicates that loop 270^275 is rather £exible. A critical role
for the structural rearrangement of this SsADH region seems
to be played not only by Gly271, one of the most conserved
residues in the ADH family, but also by Gly274 which adopts
very di¡erent conformations in the SsADH structures, deter-
mined so far.
Interestingly, compared to the native structure, a notable
movement close to the mutation also occurs at residue
Phe273. In both wt and mutant structures, this is a particu-
larly mobile residue which is exposed to the solvent displaying
high B-factors. Nevertheless, in the wt structure the side chain
is visible in its electron density and the same holds for at least
one (chain A) out of six chains of model II, where a con¢dent
modeling could be made. The side chain was instead omitted
from model I, due to the poor electron density that is barely
visible beyond the CB atom. In model II the aromatic side
chain lies on the surface and turns toward its own domain,
whereas in the wt protein it points toward the catalytic do-
main forming a stacking interaction with the imidazole ring of
His43 (Fig. 2B). The unfavorable solvent exposure of the hy-
drophobic Phe273 and its location in a loop which changes
conformation in the coenzyme low-a⁄nity mutant, suggest an
implication of this residue in the binding of the cofactor.
Finally, a further noticeable change induced by the muta-
tion is the small tilt of the N-terminal region (residues 280^
283) of KF helix which shifts away from the adjacent loop
270^275 of the other subunit in the dimer (Fig. 1).
3.3. Implications for cofactor binding
To investigate the e¡ect of N249Y substitution on coen-
zyme binding we model built the NADH molecule into its
binding site by superposition with a ternary complex structure
Fig. 1. Overall fold of the SsADH monomer (the catalytic and the
coenzyme binding domains are shown in cyan and light gray, re-
spectively). The segment 275^295 of another subunit forming a
dimer (AB) is shown in dark gray. The catalytic and structural zinc
ions are represented as green and cyan spheres, respectively. Re-
gions of structural changes compared to the wt structure are high-
lighted in di¡erent colors (46^62 green, 247^250 blue, 270^275 ma-
genta, 280^283 red).
Fig. 2. Comparison of the regions 245^252 and 268^277 between
the mutant (gray) and the wt (cyan) structures. A: The NADH mol-
ecule has been modeled by superimposing the HLADH holoenzyme
complex (PDB code 2OHX) with the SsADH mutant. The coen-
zyme binding domains of the AB dimer have been used in the
superposition. B: Interactions involving Phe273 and Asn249/Tyr
(see Sections 3.2 and 3.3). Fig. 1 and this ¢gure were drawn by the
programs Molscript [21] and Raster3D [22].
1 Here, we refer to the nomenclature of the secondary structural
elements used in [1].
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of the well-known horse liver ADH (HLADH) [13]. A core of
structurally conserved residues from the coenzyme domain of
SsADH and HLADH (see [1]) has been used in the super-
position. The structural change in the mutated enzyme has
two main consequences that can be relevant to cofactor bind-
ing at both the adenine and the nicotinamide sites.
Compared to the wt, the whole residue Asn248 is drawn
toward the NADH binding cleft thus possibly interfering with
a proper approach of the nicotinamide ribose to the Ross-
mann fold (Fig. 2A). Moreover, the displacement of Asn248
opens up the adenine binding pocket. Indeed in ADH struc-
tures the adenine ring is usually sandwiched between hydro-
phobic side chains. The alignment of SsADH with the other
ADH structures shows that these two ‘sandwich’ positions are
occupied by Val204 and by Asn248. Hence, the Asn248 dis-
placement, due to the N249Y substitution, could produce
packing de¢ciency that may well result in a poorer binding
of the adenine moiety.
A second and perhaps more important e¡ect is associated
to the orientation of the peptide plane CO270^N271. The
oxygen O270 does not point toward the NADH binding
site, as observed in wt SsADH, but toward region 247^250
and it interacts with N of Asn248 (Fig. 2A). In most of the
ADH holoenzyme structures the oxygen in this position acts
as an anchoring point of the coenzyme by forming an H-bond
to the NAD carboxamide amino group. In addition, this oxy-
gen lies in a similar position in apo and holo HLADH struc-
tures. In mutant SsADH, the N271 is shifted to the equivalent
position of the oxygen O270 as a result of the plane £ipping.
Hence, a possible stabilizing interaction (O^NH2) with the
coenzyme in the wt structure, turns into an energetically un-
favorable interaction between NH^NH2 groups in the mu-
tant.
In conclusion, molecular modeling of the bound coenzyme
suggests that the structural rearrangement induced by N249Y
substitution would produce a less well-tailored binding site for
the coenzyme. Although the mutant structure likely rear-
ranges to relieve the steric con£icts and to tighten the binding
of NAD carboxamide and adenine ring, this might be less
e⁄cient thus explaining the lower a⁄nity for NAD(H).
It is worth noting that the mutation in SsADH causes sub-
stantial structural changes in loop 270^275, whose equivalent
(292^298) in HLADH seems to be critical for the apo^holo
conformational transition [3]. In fact, mutagenesis experi-
ments performed on HLADH enzyme have shown that muta-
tions in the £exible loop comprised of residues 292^298 a¡ect
the kinetics of the enzyme and especially coenzyme binding
[14,15]. In both cases the a⁄nity for the coenzyme decreases
substantially. Crystallographic investigations of HLADH ho-
loenzyme have shown that a conformational rearrangement
of this segment is required for the ‘closure’ of the enzyme
[3]. The movement of loop 292^298 provides space for the
catalytic domain to come closer to the coenzyme binding do-
main.
It is still not clear what interactions in HLADH complexes
are responsible for triggering the conformational change from
the open to the closed form. However, several crystal struc-
tures of HLADH holo forms have pointed out that interac-
tions with the nicotinamide ring are critical for the conforma-
tional change. In fact, the enzyme crystallized with ADP-
ribose [16] or with coenzyme analogues [17,18] that are unable
to establish interactions with the nicotinamide moiety, exhib-
its an open conformational state. The substitutions in the
HLADH £exible loop, 292^298, were found to perturb the
conformational equilibrium of the protein between the open
and the closed form in the presence of the cofactor. An anal-
ogous crucial role can be suggested for loop 270^275 in
SsADH given the hypothesis of similar conformational states
for HLADH and SsADH enzymes.
3.4. Structural di¡erences remote from the substitution site
A further noteworthy ¢nding in the mutant structure con-
cerns the disorder in loop 46^62 of the catalytic domain. This
loop is located over the mouth of the active site just facing
loop 270^275 on the other domain (Fig. 1). Region 46^62
shows high thermal factors and poor de¢nition in electron
density compared to the rest of the structure.
Loop 46^62 is one of the most £exible parts of the molecule
in the wt structure too. However, the disorder appears to be
more dramatic in the structures of the mutant, regardless of
the di¡erent crystal packing environments.
Loop 46^62 is located on the interface between the two
domains, and lies opposite the loop 270^275 which is likely
to undergo a conformational transition upon cofactor bind-
ing. In HLADH the movement of the equivalent loops (51^58,
293^298) seems to be coupled. In fact, when NAD(H) binds,
residues 293^298 of the coenzyme binding domain move away
in order to make room for residues 51^58 from the catalytic
domain which rotates to close the interdomain cleft [3].
At this interdomain interface in SsADH apo structures, van
der Waals contacts are observed that involve residues Phe49,
Asn51, Leu52, Leu272, Phe273, and Leu295. The rearrange-
ment of loop 270^275 induced by the mutation may therefore
be transmitted from one domain to the other, by altering the
e⁄cient clustering of these mostly hydrophobic side chains.
As a result, the substitution can render the whole loop 46^
62 more mobile and hence a¡ect the £exibility of the active
site in the mutant structure. In fact, loop 46^62 covers the
active site and contributes to the hydrophobic channel which
is the entrance for the substrate to access the catalytic zinc [3].
Finally, an increased £exibility of this loop region in the
mutant structure could also be correlated to the di¡erent be-
havior shown by the mutated enzyme in the presence of mild
denaturing conditions. In fact, low concentrations of sodium
dodecyl sulfate (SDS) and guanidinium chloride increase the
Vmax for the wt enzyme (up to 115% by 0.05% SDS) while
leaving the mutant Vmax unaltered [6]. This is in line with
what was observed for several other enzymes which exhibit
an increased Vmax and for which a correlation was suggested
between the loosening of the active site structure and the
enzyme activation by denaturants [19,20]. In this context, it
may be surmised that diluted denaturants activate wt SsADH
by inducing an increased £exibility at the active site, whereas
the mutant is less sensitive to this e¡ect due to its intrinsic
loosening of the active site structure.
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